Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 5/20 | 0.44 |
| ▸ | CES1 | P23141 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | HSD17B3 | P37058 | 6/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31740471 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL4186060 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL1960318 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL2916184 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL28846272 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL6518862 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL2913100 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL10618776 | 0.98 | DAGLA (0.48) | DAGLAFAAHCES1HSD17B3TBXAS1 | |
| SCHEMBL7589893 | 0.95 | NPC1 (0.44) | DAGLAFAAHCES1NPC1RAB9A | |
| SCHEMBL10615856 | 0.91 | DAGLA (0.58) | DAGLAFAAHCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110002877-A1 | PTEN Inhibitors Treat Neutropenia-Associated Pneumonia | CHILDREN'S MEDICAL CENTER CORPORATION | 2011-01-06 | — | — | US | claimed |
| CN-119841912-A | Meningococcal outer membrane protein synthetic peptide and application thereof | 北京华诺泰生物医药科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| CN-119060143-A | ELISA (enzyme-linked immunosorbent assay) kit based on synthetic peptide antigen and application thereof | 中牧实业股份有限公司 | 2024-12-03 | — | — | CN | disclosed |
| CN-118812665-A | African swine fever virus p17 protein ELISA antibody detection kit | 中牧实业股份有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-115993449-B | Niu Jiejie-type dermatological virus ELISA antibody detection kit | 中牧实业股份有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-118440160-A | African swine fever virus p22 protein ELISA antibody detection kit | 中牧实业股份有限公司 | 2024-08-06 | — | — | CN | disclosed |
| CN-117777256-A | ELISA kit for clostridium perfringens toxin antibody of cattle A | 中牧实业股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117783523-A | Rabbit hemorrhagic disease virus 2 type structural protein VP60 antibody enzyme-linked immunosorbent assay kit | 中牧实业股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117777257-A | ELISA detection kit for clostridium botulinum toxin antibody of cattle C type | 中牧实业股份有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117209569-A | African swine fever virus p72 protein ELISA antibody detection kit | 中牧实业股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| US-20050164974-A1 | Nucleic acid ligand complexes | THE REGENTS OF THE UNIVERSITY OF COLORADO, SUCCESSOR IN INTEREST TO UNIVERSITY RESEARCH CORPORATION AND/OR UNIVERSITY LICENSE EQUITY HOLDINGS, INC. | 2005-07-28 | — | — | US | disclosed |
| US-20030125263-A1 | Nucleic acid ligand complexes | GILEAD SCIENCES, INC. (US) | 2003-07-03 | — | — | US | disclosed |
| US-6465188-B1 | PARTITIONING, GENETIC REPLICATION; SELEX | GILEAD SCIENCES, INC. | 2002-10-15 | — | — | US | disclosed |
| US-6147204-A | COMPLEX FOR TARGETING THERAPEUTIC OR DIAGNOSTIC AGENTS TO PREFERENTIAL BIOLOGICAL TARGET | NEXSTAR PHARMACEUTICALS, INC. (US) | 2000-11-14 | — | — | US | disclosed |
| US-6011020-A | THERAPEUTIC OR DIAGNOSTIC COMPLEX COMPRISED OF A NUCLEIC ACID LIGAND AND A POLYETHYLENE GLYCOL (PEG), WHEREIN SAID NUCLEIC ACID LIGAND IS COVALENTLY LINKED TO SAID PEG | NEXSTAR PHARMACEUTICALS, INC. (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0824541-A1 | NUCLEIC ACID LIGAND COMPLEXES | NeXstar Pharmaceuticals, Inc. (US) | 1998-02-25 | — | — | EP | disclosed |
| WO-1996034876-A1 | NUCLEIC ACID LIGAND COMPLEXES | NEXSTAR PHARMACEUTICALS, INC. (US) | 1996-11-07 | — | — | WO | disclosed |
| CN-85104463-A | Produce the method for the phosphatldylcholine and the phosphatidyl ethanolamine that respectively carry different substituents | — | 1986-12-10 | — | — | CN | disclosed |
| EP-0139670-A1 | NUTRIENT MONOESTERS | BAXTER TRAVENOL LABORATORIES, INC. (US) | 1985-05-08 | — | — | EP | disclosed |
| WO-1984003625-A1 | NUTRIENT MONOESTERS | BAXTER TRAVENOL LAB (US) | 1984-09-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110002877-A1 | PTEN Inhibitors Treat Neutropenia-Associated Pneumonia | CSF3R, CSF1R, ATM | DAGLA 1647/4885FAAH 4715/4885CES1 4535/4885 |
| US-20050164974-A1 | Nucleic acid ligand complexes | TLR9, SNRPE, HAVCR2 | DAGLA 3332/4885FAAH 3830/4885CES1 2896/4885 |
| US-20030125263-A1 | Nucleic acid ligand complexes | TLR9, SNRPE, HAVCR2 | DAGLA 3332/4885FAAH 3830/4885CES1 2896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.